A 2012 study found no significant association between Gal-3 levels and events such as CV death, acute myocardial infarction, or stroke in heart failure patients over 60 years old, a discrepancy attributed to statistical adjustment for proBNP [99]. This evidence concerns the gene NPPB and heart failure.